Tirzepatide is the most advanced weight loss medication available — clinically proven to outperform every other GLP-1 on the market. 100% online. Physician-guided. Delivered to your door.
The first and only FDA-approved dual-action weight loss peptide that targets both GIP and GLP-1 receptors — delivering results no single-pathway medication can match.
Mimics the GLP-1 hormone to reduce appetite, slow gastric emptying, and lower caloric intake. The same mechanism behind Ozempic and Wegovy — but that's only half the story.
Tirzepatide is the only weight loss medication that activates both pathways simultaneously. This dual mechanism is why clinical trials show it significantly outperforms single-pathway GLP-1s.
Activates the GIP receptor to further regulate food intake, improve insulin sensitivity, and promote efficient fat metabolism — delivering faster, more sustained weight loss.
From the landmark SURMOUNT-1 trial published in the New England Journal of Medicine — the gold standard of clinical evidence.
Mean body weight reduction at 72 weeks on the 15mg dose. Participants started at an average of 230 lbs.
9 out of 10 participants on the 15mg dose achieved clinically meaningful weight loss of 5% or more.
More than half of participants on the 15mg dose lost a fifth or more of their total body weight.
Source: Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387:205-216. SURMOUNT-1, NCT04184622.
Tirzepatide delivers improvements across your entire metabolic health profile.
Reduces blood pressure, improves cholesterol levels, and lowers cardiovascular risk markers.
Improves insulin sensitivity and HbA1c levels, originally developed for Type 2 Diabetes management.
Clinical data shows significant improvements in inflammatory biomarkers associated with chronic disease.
Naturally reduces hunger and cravings — no willpower battles. Feel satisfied with less food.
FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity.
Patients consistently report increased energy levels and improved daily vitality within weeks of starting treatment.
From sign-up to your first dose in as little as 48 hours. No clinic visits. No waiting rooms. No insurance headaches.
Fill out a quick 5-minute online health assessment. Share your goals, medical history, and current medications — all from your phone or computer.
A licensed U.S. physician reviews your intake within 48 hours. They'll evaluate your eligibility, determine the right dose, and create a personalized treatment plan.
Your prescription is filled at a licensed U.S. pharmacy and shipped cold-packed directly to your doorstep — discreet packaging, free delivery.
Monthly check-ins with your physician. Dose adjustments every 4 weeks based on your response and tolerance. Unlimited messaging with your care team.
No hidden fees. No surprise charges. Physician consultation, medication, and shipping included in every plan.
Save up to 25% with 3-month or 6-month plans. All plans include a 30-day satisfaction guarantee.
"I lost 42 lbs in 4 months. I went from XL shirts to Medium. The urge to snack just... disappeared. I have more energy than I've had in a decade."
"After years of yo-yo dieting, this is the first thing that actually worked. I'm down 35 lbs, my blood pressure is normal for the first time, and I feel incredible."
"The whole process was seamless. Signed up, got approved the next day, medication at my door in 3 days. Down 28 lbs and my doctor says my labs are the best they've been in years."
Tirzepatide is the only weight loss medication that activates both GIP and GLP-1 receptors. Semaglutide (Ozempic, Wegovy) only targets the GLP-1 pathway. In head-to-head studies, tirzepatide patients were 3.2x more likely to achieve 15%+ weight loss and lost an average of 6.9% more body weight at 12 months compared to semaglutide patients.
Tirzepatide is typically prescribed for adults with a BMI of 30+ (obesity) or BMI of 27+ with at least one weight-related health condition such as high blood pressure, high cholesterol, Type 2 diabetes, or sleep apnea. Our physicians will evaluate your eligibility during the intake review.
The most common side effects are gastrointestinal — nausea, reduced appetite, and occasional diarrhea. These are typically mild-to-moderate and most common during the initial dose escalation period. Most patients find they subside within the first few weeks. Your physician monitors and adjusts your dose to minimize side effects.
Most patients notice reduced appetite and increased energy within the first 1-2 weeks. Visible weight loss typically begins within 4-6 weeks. In clinical trials, patients lost an average of 15-21% of their body weight over 72 weeks, with significant results visible by month 3.
Tirzepatide is a once-weekly subcutaneous injection. You inject it yourself at home using a small needle — similar to an insulin pen. Most patients find it quick and virtually painless. Detailed instructions and injection supplies are included with every shipment. We also offer oral tirzepatide options for patients who prefer not to inject.
No. We offer cash-pay pricing with no insurance required — no prior authorizations, no coverage denials, no delays. Our pricing includes everything: physician consultation, medication, injection supplies, and free shipping. We also accept FSA/HSA cards.
Clinical research shows that weight regain can occur after discontinuation. That's why our program includes maintenance planning — your physician works with you to find the lowest effective maintenance dose or create a transition plan with lifestyle modifications to help sustain your results long-term.
Take our free 5-minute health assessment to see if tirzepatide is right for you. No obligations. No credit card required.
Start My Free Assessment